Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye-Chan Park

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Experimental & Molecular Medicine|June 30, 2024
PHGDH: a novel therapeutic target in cancerChae Min Lee, Yeseong Hwang, Minki Kim, et al.
Pharmaceutics|December 31, 2025
Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 StudyYe Chan Park, Eunyoung Seol, Jongmi Lee, et al.
Scientific Reports|September 12, 2023
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanomaKyu-Hye Chun, Ye-Chan Park, Nahee Hwang, et al.
Translational and Clinical Pharmacology|April 10, 2025
Clinical data warehouse analysis of clinical laboratory test results of Korean healthy volunteers: does "not clinically significant" range of healthy volunteers need modification?Cheol Joong Kim, Tak Don Kim, Ye Chan Park, et al.
Biomolecules & Therapeutics|February 27, 2026
Exploring <i>LEPR</i>-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese AdultsKyeong-Seog Kim, Joo-Youn Cho, Ye Chan Park, et al.
Clinical and Translational Science|October 1, 2024
Pharmacokinetic comparison of subcutaneously administered CT-P13 (biosimilar of infliximab) via autoinjector and pre-filled syringe in healthy participantsYe Chan Park, Jae Hoon Kim, Sung Hyun Kim, et al.
Cell Death Discovery|February 14, 2025
One-carbon metabolism is distinct metabolic signature for proliferative intermediate exhausted T cells of ICB-resistant cancer patientsYe-Chan Park, Yeseong Hwang, Jae Woong Jeong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Experimental & Molecular Medicine|June 30, 2024
PHGDH: a novel therapeutic target in cancerChae Min Lee, Yeseong Hwang, Minki Kim, et al.
Pharmaceutics|December 31, 2025
Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 StudyYe Chan Park, Eunyoung Seol, Jongmi Lee, et al.
Scientific Reports|September 12, 2023
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanomaKyu-Hye Chun, Ye-Chan Park, Nahee Hwang, et al.
Translational and Clinical Pharmacology|April 10, 2025
Clinical data warehouse analysis of clinical laboratory test results of Korean healthy volunteers: does "not clinically significant" range of healthy volunteers need modification?Cheol Joong Kim, Tak Don Kim, Ye Chan Park, et al.
Biomolecules & Therapeutics|February 27, 2026
Exploring <i>LEPR</i>-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese AdultsKyeong-Seog Kim, Joo-Youn Cho, Ye Chan Park, et al.
Clinical and Translational Science|October 1, 2024
Pharmacokinetic comparison of subcutaneously administered CT-P13 (biosimilar of infliximab) via autoinjector and pre-filled syringe in healthy participantsYe Chan Park, Jae Hoon Kim, Sung Hyun Kim, et al.
Cell Death Discovery|February 14, 2025
One-carbon metabolism is distinct metabolic signature for proliferative intermediate exhausted T cells of ICB-resistant cancer patientsYe-Chan Park, Yeseong Hwang, Jae Woong Jeong, et al.
Pageof 1